drugset / Trial / NCT06475417
Neoadjuvant Adebrelimab + DOS in Locally Advanced Resectable Gastric Cancer
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the efficacy and safety of adebrelimab combined DOS in neoadjuvant treatment of locally advanced resectable gastric cancer.
Timeline
- Start
- 2024-05-24
- Primary completion
- 2025-05-20
- Completion
- 2026-04-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adebrelimab | Monoclonal antibody | — | — |
| Subject | Docetaxel | Small molecule | — | — |
| Subject | Oxaliplatin | Small molecule | — | — |
| Subject | S-1 | Small molecule | — | — |